BACKGROUND: Strategies are needed to improve the translation of clinical trial results into practice. We assessed the impact of the ALLHAT/JNC7 Dissemination Project's academic detailing component on thiazide-type diuretic prescribing (ALLHAT indicates Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial; JNC7 indicates the Seventh Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure). METHODS: We used 2 national databases available from IMS Health: a physician survey of medications reported for hypertension and a pharmacy dispensing database on antihypertensive medications. At a county level, we correlated medication data with Dissemination Project intensity. Practices before the Dissemination Project in 2004 were compared with those after its completion in 2007. We also examined 2000-2008 national trends. RESULTS: Academic detailing reached 18 524 physicians in 1698 venues via 147 investigator-educators. We noted an association between ALLHAT/JNC7 academic detailing activities and increased prescribing of thiazide-type diuretics. Physician survey data showed that the percentage of hypertension visits where the physician recorded a thiazide-type diuretic increased the most in counties where academic detailing activity was the highest (an increase of 8.6%, from 37.9% to 46.5%) compared with counties where activity was moderate (an increase of 2%) or low (a decrease of 2%), or where there was none (an increase of 2%; P value for trend, <.05). Pharmacy dispensing data showed that thiazide-type diuretic prescribing increased by 8.7% in counties with Dissemination Project activities compared with 3.9% in those without activities (P < .001). Nationally, thiazide-type diuretic use did not increase between 2004 and 2008. CONCLUSIONS: The ALLHAT/JNC7 Dissemination Project was associated with a small effect on thiazide-type diuretic use consistent with its small dose and the potential of external factors to diminish its impact. Academic detailing may increase physicians' implementation of clinical trial results, thereby making prescribing more consistent with evidence.
BACKGROUND: Strategies are needed to improve the translation of clinical trial results into practice. We assessed the impact of the ALLHAT/JNC7 Dissemination Project's academic detailing component on thiazide-type diuretic prescribing (ALLHAT indicates Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial; JNC7 indicates the Seventh Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure). METHODS: We used 2 national databases available from IMS Health: a physician survey of medications reported for hypertension and a pharmacy dispensing database on antihypertensive medications. At a county level, we correlated medication data with Dissemination Project intensity. Practices before the Dissemination Project in 2004 were compared with those after its completion in 2007. We also examined 2000-2008 national trends. RESULTS: Academic detailing reached 18 524 physicians in 1698 venues via 147 investigator-educators. We noted an association between ALLHAT/JNC7 academic detailing activities and increased prescribing of thiazide-type diuretics. Physician survey data showed that the percentage of hypertension visits where the physician recorded a thiazide-type diuretic increased the most in counties where academic detailing activity was the highest (an increase of 8.6%, from 37.9% to 46.5%) compared with counties where activity was moderate (an increase of 2%) or low (a decrease of 2%), or where there was none (an increase of 2%; P value for trend, <.05). Pharmacy dispensing data showed that thiazide-type diuretic prescribing increased by 8.7% in counties with Dissemination Project activities compared with 3.9% in those without activities (P < .001). Nationally, thiazide-type diuretic use did not increase between 2004 and 2008. CONCLUSIONS: The ALLHAT/JNC7 Dissemination Project was associated with a small effect on thiazide-type diuretic use consistent with its small dose and the potential of external factors to diminish its impact. Academic detailing may increase physicians' implementation of clinical trial results, thereby making prescribing more consistent with evidence.
Authors: Steven R Simon; Sumit R Majumdar; Lisa A Prosser; Susanne Salem-Schatz; Cheryl Warner; Ken Kleinman; Irina Miroshnik; Stephen B Soumerai Journal: Am J Med Date: 2005-05 Impact factor: 4.965
Authors: M A O'Brien; S Rogers; G Jamtvedt; A D Oxman; J Odgaard-Jensen; D T Kristoffersen; L Forsetlund; D Bainbridge; N Freemantle; D A Davis; R B Haynes; E L Harvey Journal: Cochrane Database Syst Rev Date: 2007-10-17
Authors: Jackson T Wright; Jeffrey L Probstfield; William C Cushman; Sara L Pressel; Jeffrey A Cutler; Barry R Davis; Paula T Einhorn; Mahboob Rahman; Paul K Whelton; Charles E Ford; L Julian Haywood; Karen L Margolis; Suzanne Oparil; Henry R Black; Michael H Alderman Journal: Arch Intern Med Date: 2009-05-11
Authors: L Kay Bartholomew; William C Cushman; Jeffrey A Cutler; Barry R Davis; Glenna Dawson; Paula T Einhorn; James F Graumlich; Linda B Piller; Sara Pressel; Edward J Roccella; Lara Simpson; Paul K Whelton; Angela Williard Journal: Clin Trials Date: 2009-07-08 Impact factor: 2.486
Authors: Margaret Jin; Terryn Naumann; Loren Regier; Shawn Bugden; Michael Allen; Lena Salach; Kristen Chelak; Nancy Blythe; Antony Gagnon; Lisa Dolovich Journal: Can Pharm J (Ott) Date: 2012-05
Authors: Tara I Chang; Gregory Evans; Alfred K Cheung; William C Cushman; Matthew J Diamond; Jamie P Dwyer; Yonghong Huan; Dalane Kitzman; John B Kostis; Suzanne Oparil; Anjay Rastogi; Christianne L Roumie; Rukmani Sahay; Randall S Stafford; Addison A Taylor; Jackson T Wright; Glenn M Chertow Journal: Hypertension Date: 2016-01-25 Impact factor: 10.190
Authors: Linda M Gerber; Samuel J Mann; Margaret V McDonald; Ya-Lin Chiu; Sridevi Sridharan; Penny H Feldman Journal: Am J Hypertens Date: 2012-12-28 Impact factor: 2.689
Authors: Cristiano S Moura; Stella S Daskalopoulou; Linda E Levesque; Sasha Bernatsky; Michal Abrahamowicz; Meytal A Tsadok; Shadi Rajabi; Louise Pilote Journal: J Clin Hypertens (Greenwich) Date: 2015-07-20 Impact factor: 3.738
Authors: Tatsuo Hosoya; Satoru Kuriyama; Iwao Ohno; Tetsuya Kawamura; Makoto Ogura; Masato Ikeda; Masahiro Ishikawa; Fumihiro Hayashi; Tatsuya Kanai; Haruo Tomonari; Michimasa Soejima; Kiyoaki Akaba; Goro Tokudome; S Endo; A Fukui; H Gomi; A Hamaguchi; K Hanaoka; Y Hara; Y Hara; T Hasegawa; H Hayakawa; M Hikida; K Hirano; M Horiguchi; M Hosoya; K Ichida; T Imai; T Ishii; H Ishikawa; C Kameda; T Kasai; A Kobayashi; H Kobayashi; M Kurashige; Y Kusama; H Maezawa; Y Maezawa; Y Maruyama; H Matsuda; N Matsuo; T Matsuo; Y Miura; M Miyajima; M Miyakawa; Y Miyazaki; M Mizuguchi; M Nakao; H Nokano; I Ohkido; Y Ohtsuka; K Okada; H Okamoto; H Okonogi; H Saikawa; H Saito; C Sekiguchi; Y Suetsugu; N Sugano; T Suzuki; T Suzuki; H Takahashi; Y Takahashi; S Takamizawa; K Takane; T Morita; K Takazoe; H Tanaka; S Tanaka; H Terawaki; R Toyoshima; N Tsuboi; T Udagawa; H Ueda; Y Ueda; M Uetake; S Unemura; M Utsunomiya; Y Utsunomiya; T Yamada; Y Yamada; Y Yamaguchi; H Yamamoto; T Yokoo; K Yokoyama; H Yonezawa; H Yoshida; M Yoshida; T Yoshizawa Journal: Clin Exp Nephrol Date: 2011-11-30 Impact factor: 2.801